Search research articles
Contact Us
Filters
Showing results (11-20 of 350) with videos related to
Page
of 35
Sort By:
The American Journal of Surgical Pathology
|
April 26, 2012
Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia
Mindaugas Andrulis, Roland Penzel, Wilko Weichert, et al.
Journal of Neurosurgery. Case Lessons
|
January 22, 2026
The great imitator: clinical, surgical, and molecular insights into diffuse midline gliomas, H3 K27-altered. Illustrative cases
Jan Hellmeyer, Lennart W Sannwald, Mats L Moskopp, et al.
Acta Neuropathologica
|
October 11, 2011
Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma
Jens Schittenhelm, Michel Mittelbronn, Richard Meyermann, et al.
World Neurosurgery
|
March 11, 2015
Intramedullary Solitary Fibrous Tumor--A Benign Form of Hemangiopericytoma? Case Report and Review of the Literature
Markus Bruder, Dominique Tews, Michel Mittelbronn, et al.
Neuro-Oncology Practice
|
January 8, 2025
Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma
Patrick Roth, David Capper, Evan Calabrese, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 24, 2022
DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas
Philipp Jurmeister, Maximilian Leitheiser, Peggy Wolkenstein, et al.
Leukemia Research
|
March 16, 2010
Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing
Mindaugas Andrulis, David Capper, Thomas Luft, et al.
The American Journal of Surgical Pathology
|
July 28, 2010
Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes
David Capper, Felix Sahm, Christian Hartmann, et al.
Pathology
|
March 12, 2014
The embryonic stem cell factor UTF1 serves as a reliable diagnostic marker for germinomas
Georgios Pantazis, Patrick N Harter, David Capper, et al.
Brain Pathology (Zurich, Switzerland)
|
May 10, 2020
An 8-Year-Old Girl with Posterior Fossa Mass
Viktoria C Ruf, Anne Schöler, David Capper, et al.
Page
of 35
Search research articles
Search
Showing results (11-20 of 350) with videos related to
Sort By:
Page
of 35
The American Journal of Surgical Pathology
|
April 26, 2012
Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia
Mindaugas Andrulis, Roland Penzel, Wilko Weichert, et al.
Journal of Neurosurgery. Case Lessons
|
January 22, 2026
The great imitator: clinical, surgical, and molecular insights into diffuse midline gliomas, H3 K27-altered. Illustrative cases
Jan Hellmeyer, Lennart W Sannwald, Mats L Moskopp, et al.
Acta Neuropathologica
|
October 11, 2011
Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma
Jens Schittenhelm, Michel Mittelbronn, Richard Meyermann, et al.
World Neurosurgery
|
March 11, 2015
Intramedullary Solitary Fibrous Tumor--A Benign Form of Hemangiopericytoma? Case Report and Review of the Literature
Markus Bruder, Dominique Tews, Michel Mittelbronn, et al.
Neuro-Oncology Practice
|
January 8, 2025
Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma
Patrick Roth, David Capper, Evan Calabrese, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 24, 2022
DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas
Philipp Jurmeister, Maximilian Leitheiser, Peggy Wolkenstein, et al.
Leukemia Research
|
March 16, 2010
Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing
Mindaugas Andrulis, David Capper, Thomas Luft, et al.
The American Journal of Surgical Pathology
|
July 28, 2010
Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes
David Capper, Felix Sahm, Christian Hartmann, et al.
Pathology
|
March 12, 2014
The embryonic stem cell factor UTF1 serves as a reliable diagnostic marker for germinomas
Georgios Pantazis, Patrick N Harter, David Capper, et al.
Brain Pathology (Zurich, Switzerland)
|
May 10, 2020
An 8-Year-Old Girl with Posterior Fossa Mass
Viktoria C Ruf, Anne Schöler, David Capper, et al.
Page
of 35